Global Anti-Parkinson Drugs Market Growth (Status and Outlook) 2022-2028
- LP 4805911
- 101 Pages
- January 2022
- Pharmaceuticals
The United States Anti-Parkinson Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anti-Parkinson Drugs market, reaching US$ million by the year 2028. As for the Europe Anti-Parkinson Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Anti-Parkinson Drugs players cover AbbVie, Mylan Laboratories, Valeant Pharmaceuticals, and Novartis, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Parkinson Drugs market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Dopaminergic
Dopamine Agonists
Enzyme Inhibitors
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacy
Retail Pharmacy
Online Stores
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
AbbVie
Mylan Laboratories
Valeant Pharmaceuticals
Novartis
GlaxoSmithKline
Zambon Pharmaceuticals
Pfizer, Inc.
Hoffmann-La Roche
Merck & Co.
Orion Pharma
UCB
Teva Pharmaceutical Industries Ltd.
Vertical Pharmaceuticals, LLC
ACADIA Pharmaceuticals Inc.
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Anti-Parkinson Drugs Market Size 2017-2028
2.1.2 Anti-Parkinson Drugs Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Anti-Parkinson Drugs Segment by Type
2.2.1 Dopaminergic
2.2.2 Dopamine Agonists
2.2.3 Enzyme Inhibitors
2.2.4 Others
2.3 Anti-Parkinson Drugs Market Size by Type
2.3.1 Anti-Parkinson Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Anti-Parkinson Drugs Market Size Market Share by Type (2017-2022)
2.4 Anti-Parkinson Drugs Segment by Application
2.4.1 Hospital Pharmacy
2.4.2 Retail Pharmacy
2.4.3 Online Stores
2.5 Anti-Parkinson Drugs Market Size by Application
2.5.1 Anti-Parkinson Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Anti-Parkinson Drugs Market Size Market Share by Application (2017-2022)
3 Anti-Parkinson Drugs Market Size by Player
3.1 Anti-Parkinson Drugs Market Size Market Share by Players
3.1.1 Global Anti-Parkinson Drugs Revenue by Players (2020-2022)
3.1.2 Global Anti-Parkinson Drugs Revenue Market Share by Players (2020-2022)
3.2 Global Anti-Parkinson Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Anti-Parkinson Drugs by Regions
4.1 Anti-Parkinson Drugs Market Size by Regions (2017-2022)
4.2 Americas Anti-Parkinson Drugs Market Size Growth (2017-2022)
4.3 APAC Anti-Parkinson Drugs Market Size Growth (2017-2022)
4.4 Europe Anti-Parkinson Drugs Market Size Growth (2017-2022)
4.5 Middle East & Africa Anti-Parkinson Drugs Market Size Growth (2017-2022)
5 Americas
5.1 Americas Anti-Parkinson Drugs Market Size by Country (2017-2022)
5.2 Americas Anti-Parkinson Drugs Market Size by Type (2017-2022)
5.3 Americas Anti-Parkinson Drugs Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Anti-Parkinson Drugs Market Size by Region (2017-2022)
6.2 APAC Anti-Parkinson Drugs Market Size by Type (2017-2022)
6.3 APAC Anti-Parkinson Drugs Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Anti-Parkinson Drugs by Country (2017-2022)
7.2 Europe Anti-Parkinson Drugs Market Size by Type (2017-2022)
7.3 Europe Anti-Parkinson Drugs Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Anti-Parkinson Drugs by Region (2017-2022)
8.2 Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2017-2022)
8.3 Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Anti-Parkinson Drugs Market Forecast
10.1 Global Anti-Parkinson Drugs Forecast by Regions (2023-2028)
10.1.1 Global Anti-Parkinson Drugs Forecast by Regions (2023-2028)
10.1.2 Americas Anti-Parkinson Drugs Forecast
10.1.3 APAC Anti-Parkinson Drugs Forecast
10.1.4 Europe Anti-Parkinson Drugs Forecast
10.1.5 Middle East & Africa Anti-Parkinson Drugs Forecast
10.2 Americas Anti-Parkinson Drugs Forecast by Country (2023-2028)
10.2.1 United States Anti-Parkinson Drugs Market Forecast
10.2.2 Canada Anti-Parkinson Drugs Market Forecast
10.2.3 Mexico Anti-Parkinson Drugs Market Forecast
10.2.4 Brazil Anti-Parkinson Drugs Market Forecast
10.3 APAC Anti-Parkinson Drugs Forecast by Region (2023-2028)
10.3.1 China Anti-Parkinson Drugs Market Forecast
10.3.2 Japan Anti-Parkinson Drugs Market Forecast
10.3.3 Korea Anti-Parkinson Drugs Market Forecast
10.3.4 Southeast Asia Anti-Parkinson Drugs Market Forecast
10.3.5 India Anti-Parkinson Drugs Market Forecast
10.3.6 Australia Anti-Parkinson Drugs Market Forecast
10.4 Europe Anti-Parkinson Drugs Forecast by Country (2023-2028)
10.4.1 Germany Anti-Parkinson Drugs Market Forecast
10.4.2 France Anti-Parkinson Drugs Market Forecast
10.4.3 UK Anti-Parkinson Drugs Market Forecast
10.4.4 Italy Anti-Parkinson Drugs Market Forecast
10.4.5 Russia Anti-Parkinson Drugs Market Forecast
10.5 Middle East & Africa Anti-Parkinson Drugs Forecast by Region (2023-2028)
10.5.1 Egypt Anti-Parkinson Drugs Market Forecast
10.5.2 South Africa Anti-Parkinson Drugs Market Forecast
10.5.3 Israel Anti-Parkinson Drugs Market Forecast
10.5.4 Turkey Anti-Parkinson Drugs Market Forecast
10.5.5 GCC Countries Anti-Parkinson Drugs Market Forecast
10.6 Global Anti-Parkinson Drugs Forecast by Type (2023-2028)
10.7 Global Anti-Parkinson Drugs Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Anti-Parkinson Drugs Product Offered
11.1.3 AbbVie Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Mylan Laboratories
11.2.1 Mylan Laboratories Company Information
11.2.2 Mylan Laboratories Anti-Parkinson Drugs Product Offered
11.2.3 Mylan Laboratories Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Mylan Laboratories Main Business Overview
11.2.5 Mylan Laboratories Latest Developments
11.3 Valeant Pharmaceuticals
11.3.1 Valeant Pharmaceuticals Company Information
11.3.2 Valeant Pharmaceuticals Anti-Parkinson Drugs Product Offered
11.3.3 Valeant Pharmaceuticals Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Valeant Pharmaceuticals Main Business Overview
11.3.5 Valeant Pharmaceuticals Latest Developments
11.4 Novartis
11.4.1 Novartis Company Information
11.4.2 Novartis Anti-Parkinson Drugs Product Offered
11.4.3 Novartis Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Novartis Main Business Overview
11.4.5 Novartis Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Anti-Parkinson Drugs Product Offered
11.5.3 GlaxoSmithKline Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Zambon Pharmaceuticals
11.6.1 Zambon Pharmaceuticals Company Information
11.6.2 Zambon Pharmaceuticals Anti-Parkinson Drugs Product Offered
11.6.3 Zambon Pharmaceuticals Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Zambon Pharmaceuticals Main Business Overview
11.6.5 Zambon Pharmaceuticals Latest Developments
11.7 Pfizer, Inc.
11.7.1 Pfizer, Inc. Company Information
11.7.2 Pfizer, Inc. Anti-Parkinson Drugs Product Offered
11.7.3 Pfizer, Inc. Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Pfizer, Inc. Main Business Overview
11.7.5 Pfizer, Inc. Latest Developments
11.8 Hoffmann-La Roche
11.8.1 Hoffmann-La Roche Company Information
11.8.2 Hoffmann-La Roche Anti-Parkinson Drugs Product Offered
11.8.3 Hoffmann-La Roche Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Hoffmann-La Roche Main Business Overview
11.8.5 Hoffmann-La Roche Latest Developments
11.9 Merck & Co.
11.9.1 Merck & Co. Company Information
11.9.2 Merck & Co. Anti-Parkinson Drugs Product Offered
11.9.3 Merck & Co. Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Merck & Co. Main Business Overview
11.9.5 Merck & Co. Latest Developments
11.10 Orion Pharma
11.10.1 Orion Pharma Company Information
11.10.2 Orion Pharma Anti-Parkinson Drugs Product Offered
11.10.3 Orion Pharma Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Orion Pharma Main Business Overview
11.10.5 Orion Pharma Latest Developments
11.11 UCB
11.11.1 UCB Company Information
11.11.2 UCB Anti-Parkinson Drugs Product Offered
11.11.3 UCB Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 UCB Main Business Overview
11.11.5 UCB Latest Developments
11.12 Teva Pharmaceutical Industries Ltd.
11.12.1 Teva Pharmaceutical Industries Ltd. Company Information
11.12.2 Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Product Offered
11.12.3 Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Teva Pharmaceutical Industries Ltd. Main Business Overview
11.12.5 Teva Pharmaceutical Industries Ltd. Latest Developments
11.13 Vertical Pharmaceuticals, LLC
11.13.1 Vertical Pharmaceuticals, LLC Company Information
11.13.2 Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Product Offered
11.13.3 Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Vertical Pharmaceuticals, LLC Main Business Overview
11.13.5 Vertical Pharmaceuticals, LLC Latest Developments
11.14 ACADIA Pharmaceuticals Inc.
11.14.1 ACADIA Pharmaceuticals Inc. Company Information
11.14.2 ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Product Offered
11.14.3 ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 ACADIA Pharmaceuticals Inc. Main Business Overview
11.14.5 ACADIA Pharmaceuticals Inc. Latest Developments
12 Research Findings and Conclusion
Table 1. Anti-Parkinson Drugs Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Dopaminergic
Table 3. Major Players of Dopamine Agonists
Table 4. Major Players of Enzyme Inhibitors
Table 5. Major Players of Others
Table 6. Anti-Parkinson Drugs Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Anti-Parkinson Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Anti-Parkinson Drugs Market Size Market Share by Type (2017-2022)
Table 9. Anti-Parkinson Drugs Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Anti-Parkinson Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Anti-Parkinson Drugs Market Size Market Share by Application (2017-2022)
Table 12. Global Anti-Parkinson Drugs Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Anti-Parkinson Drugs Revenue Market Share by Player (2020-2022)
Table 14. Anti-Parkinson Drugs Key Players Head office and Products Offered
Table 15. Anti-Parkinson Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Anti-Parkinson Drugs Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Anti-Parkinson Drugs Market Size Market Share by Regions (2017-2022)
Table 20. Americas Anti-Parkinson Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Anti-Parkinson Drugs Market Size Market Share by Country (2017-2022)
Table 22. Americas Anti-Parkinson Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Anti-Parkinson Drugs Market Size Market Share by Type (2017-2022)
Table 24. Americas Anti-Parkinson Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Anti-Parkinson Drugs Market Size Market Share by Application (2017-2022)
Table 26. APAC Anti-Parkinson Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Anti-Parkinson Drugs Market Size Market Share by Region (2017-2022)
Table 28. APAC Anti-Parkinson Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Anti-Parkinson Drugs Market Size Market Share by Type (2017-2022)
Table 30. APAC Anti-Parkinson Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Anti-Parkinson Drugs Market Size Market Share by Application (2017-2022)
Table 32. Europe Anti-Parkinson Drugs Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Anti-Parkinson Drugs Market Size Market Share by Country (2017-2022)
Table 34. Europe Anti-Parkinson Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Anti-Parkinson Drugs Market Size Market Share by Type (2017-2022)
Table 36. Europe Anti-Parkinson Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Anti-Parkinson Drugs Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Anti-Parkinson Drugs Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Anti-Parkinson Drugs Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Anti-Parkinson Drugs Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Anti-Parkinson Drugs Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Anti-Parkinson Drugs Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Anti-Parkinson Drugs Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Anti-Parkinson Drugs
Table 45. Key Market Challenges & Risks of Anti-Parkinson Drugs
Table 46. Key Industry Trends of Anti-Parkinson Drugs
Table 47. Global Anti-Parkinson Drugs Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Anti-Parkinson Drugs Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Anti-Parkinson Drugs Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Anti-Parkinson Drugs Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Anti-Parkinson Drugs Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Anti-Parkinson Drugs Market Size Market Share Forecast by Application (2023-2028)
Table 53. AbbVie Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 54. AbbVie Anti-Parkinson Drugs Product Offered
Table 55. AbbVie Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. AbbVie Main Business
Table 57. AbbVie Latest Developments
Table 58. Mylan Laboratories Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 59. Mylan Laboratories Anti-Parkinson Drugs Product Offered
Table 60. Mylan Laboratories Main Business
Table 61. Mylan Laboratories Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Mylan Laboratories Latest Developments
Table 63. Valeant Pharmaceuticals Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 64. Valeant Pharmaceuticals Anti-Parkinson Drugs Product Offered
Table 65. Valeant Pharmaceuticals Main Business
Table 66. Valeant Pharmaceuticals Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Valeant Pharmaceuticals Latest Developments
Table 68. Novartis Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 69. Novartis Anti-Parkinson Drugs Product Offered
Table 70. Novartis Main Business
Table 71. Novartis Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Novartis Latest Developments
Table 73. GlaxoSmithKline Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 74. GlaxoSmithKline Anti-Parkinson Drugs Product Offered
Table 75. GlaxoSmithKline Main Business
Table 76. GlaxoSmithKline Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. GlaxoSmithKline Latest Developments
Table 78. Zambon Pharmaceuticals Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 79. Zambon Pharmaceuticals Anti-Parkinson Drugs Product Offered
Table 80. Zambon Pharmaceuticals Main Business
Table 81. Zambon Pharmaceuticals Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Zambon Pharmaceuticals Latest Developments
Table 83. Pfizer, Inc. Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 84. Pfizer, Inc. Anti-Parkinson Drugs Product Offered
Table 85. Pfizer, Inc. Main Business
Table 86. Pfizer, Inc. Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Pfizer, Inc. Latest Developments
Table 88. Hoffmann-La Roche Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 89. Hoffmann-La Roche Anti-Parkinson Drugs Product Offered
Table 90. Hoffmann-La Roche Main Business
Table 91. Hoffmann-La Roche Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Hoffmann-La Roche Latest Developments
Table 93. Merck & Co. Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 94. Merck & Co. Anti-Parkinson Drugs Product Offered
Table 95. Merck & Co. Main Business
Table 96. Merck & Co. Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Merck & Co. Latest Developments
Table 98. Orion Pharma Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 99. Orion Pharma Anti-Parkinson Drugs Product Offered
Table 100. Orion Pharma Main Business
Table 101. Orion Pharma Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Orion Pharma Latest Developments
Table 103. UCB Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 104. UCB Anti-Parkinson Drugs Product Offered
Table 105. UCB Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. UCB Main Business
Table 107. UCB Latest Developments
Table 108. Teva Pharmaceutical Industries Ltd. Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 109. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Product Offered
Table 110. Teva Pharmaceutical Industries Ltd. Main Business
Table 111. Teva Pharmaceutical Industries Ltd. Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Teva Pharmaceutical Industries Ltd. Latest Developments
Table 113. Vertical Pharmaceuticals, LLC Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 114. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Product Offered
Table 115. Vertical Pharmaceuticals, LLC Main Business
Table 116. Vertical Pharmaceuticals, LLC Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 117. Vertical Pharmaceuticals, LLC Latest Developments
Table 118. ACADIA Pharmaceuticals Inc. Details, Company Type, Anti-Parkinson Drugs Area Served and Its Competitors
Table 119. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Product Offered
Table 120. ACADIA Pharmaceuticals Inc. Main Business
Table 121. ACADIA Pharmaceuticals Inc. Anti-Parkinson Drugs Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 122. ACADIA Pharmaceuticals Inc. Latest Developments
List of Figures
Figure 1. Anti-Parkinson Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Anti-Parkinson Drugs Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Anti-Parkinson Drugs Market Size Market Share by Type in 2021
Figure 7. Anti-Parkinson Drugs in Hospital Pharmacy
Figure 8. Global Anti-Parkinson Drugs Market: Hospital Pharmacy (2017-2022) & ($ Millions)
Figure 9. Anti-Parkinson Drugs in Retail Pharmacy
Figure 10. Global Anti-Parkinson Drugs Market: Retail Pharmacy (2017-2022) & ($ Millions)
Figure 11. Anti-Parkinson Drugs in Online Stores
Figure 12. Global Anti-Parkinson Drugs Market: Online Stores (2017-2022) & ($ Millions)
Figure 13. Global Anti-Parkinson Drugs Market Size Market Share by Application in 2021
Figure 14. Global Anti-Parkinson Drugs Revenue Market Share by Player in 2021
Figure 15. Global Anti-Parkinson Drugs Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Anti-Parkinson Drugs Market Size 2017-2022 ($ Millions)
Figure 17. APAC Anti-Parkinson Drugs Market Size 2017-2022 ($ Millions)
Figure 18. Europe Anti-Parkinson Drugs Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Anti-Parkinson Drugs Market Size 2017-2022 ($ Millions)
Figure 20. Americas Anti-Parkinson Drugs Value Market Share by Country in 2021
Figure 21. Americas Anti-Parkinson Drugs Consumption Market Share by Type in 2021
Figure 22. Americas Anti-Parkinson Drugs Market Size Market Share by Application in 2021
Figure 23. United States Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Anti-Parkinson Drugs Market Size Market Share by Region in 2021
Figure 28. APAC Anti-Parkinson Drugs Market Size Market Share by Application in 2021
Figure 29. China Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Anti-Parkinson Drugs Market Size Market Share by Country in 2021
Figure 36. Europe Anti-Parkinson Drugs Market Size Market Share by Type in 2021
Figure 37. Europe Anti-Parkinson Drugs Market Size Market Share by Application in 2021
Figure 38. Germany Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Anti-Parkinson Drugs Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Anti-Parkinson Drugs Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Anti-Parkinson Drugs Market Size Market Share by Application in 2021
Figure 46. Egypt Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Anti-Parkinson Drugs Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 52. APAC Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 53. Europe Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 55. United States Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 56. Canada Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 59. China Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 60. Japan Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 61. Korea Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 63. India Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 64. Australia Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 65. Germany Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 66. France Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 67. UK Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 68. Italy Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 69. Russia Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 70. Spain Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 73. Israel Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Anti-Parkinson Drugs Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
